Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GFAP ELISA Kit (AC3774)
Cat.#: ASET-2363
Specifications
Description Human GFAP ELISA Kit allows for the in vitro quantitative determination of human GFAP concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1577 Mouse Noradrenaline Transporter ELISA Kit (AC2988) Quantitative inquiry ASET-2136 Human 5HT2A Receptor ELISA Kit (AC3547) Quantitative inquiry ASET-2275 Human Calbindin ELISA Kit (AC3686) Quantitative inquiry ASET-1537 Rat EAAT3 ELISA Kit (AC2948) Quantitative inquiry ASET-1960 Human NOX3 ELISA Kit (AC3371) Quantitative inquiry ASET-1252 Human Granuphilin ELISA Kit (AC2663) Quantitative inquiry ASET-1403 Rabbit Fatty Acid Synthase ELISA Kit (AC2814) Quantitative inquiry ASET-1610 Human Orexin A ELISA Kit (AC3021) Quantitative inquiry ASET-1122 Rat CX3CR1 ELISA Kit (AC2533) Quantitative inquiry ASET-1821 Human Adenosine A1 Receptor ELISA Kit (AC3232) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket